Skip to main content
Top
Published in: Rheumatology and Therapy 4/2021

Open Access 01-12-2021 | Sarilumab | Correction

Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data

Authors: Markus Rehberg, Clemens Giegerich, Amy Praestgaard, Hubert van Hoogstraten, Melitza Iglesias-Rodriguez, Jeffrey R. Curtis, Jacques-Eric Gottenberg, Andreas Schwarting, Santos Castañeda, Andrea Rubbert-Roth, Ernest H. S. Choy, the MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators

Published in: Rheumatology and Therapy | Issue 4/2021

Login to get access

Excerpt

In the original article published, there is an error in the video of the supplementary material. The correct supplementary material has been updated. …
Appendix
Available only for authorised users
Metadata
Title
Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Authors
Markus Rehberg
Clemens Giegerich
Amy Praestgaard
Hubert van Hoogstraten
Melitza Iglesias-Rodriguez
Jeffrey R. Curtis
Jacques-Eric Gottenberg
Andreas Schwarting
Santos Castañeda
Andrea Rubbert-Roth
Ernest H. S. Choy
the MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators
Publication date
01-12-2021
Publisher
Springer Healthcare
Published in
Rheumatology and Therapy / Issue 4/2021
Print ISSN: 2198-6576
Electronic ISSN: 2198-6584
DOI
https://doi.org/10.1007/s40744-021-00389-7

Other articles of this Issue 4/2021

Rheumatology and Therapy 4/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine